EnglishFrenchGermanItalianSpanish

WELCOME TO THE NEWSROOM

WATCH OUR LATEST VIDEO

In the news

Find our most recent press releases and other media below. CONTACT US if you need more details, would like to set up an interview or are a media person on deadline.

Ann Arbor, MI (October 16, 2019) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today an agreement with Self-screen BV to implement a CE-IVD marked molecular diagnostic test for high-risk strains of human papillomavirus (HPV) on the NeuMoDx™ 288 and NeuMoDx™ 96 Molecular Systems. HPV is the virus regarded...

Ann Arbor, MI (July 23, 2019) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today the launch of CE-IVD assays for Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV). Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) are herpes viruses found in up to 90% of the adult population.  Usually latent, the presence...

Ann Arbor, MI (June 21, 2019) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today the launch of CE-IVD assays for Hepatitis B virus (HBV) and Hepatitis C virus (HCV). Hepatitis infections are more frequent in immunocompromised populations than in the general population with lower rates of spontaneous recovery...

If you’re in Savannah, Georgia this week for the American Society for Microbiology’s Clinical Virology Symposium, NeuMoDx™ teammate Jason has a message for you! Stop by booth #547 now through Wednesday, May 8 at #ASMCVS – we can’t wait to show you the future of molecular diagnostics.